This week in the 2016 Conference Coverage section, we’ve posted the second half of the interview with Dr. Jeffrey Jones from EHA. We had posted the first half of the interview on the role of venetoclax in CLL in The CLL Tribune.
http://www.cllsociety.org/newsletter/quarter-2-2016-volume-2-issue-2/interview-2016-eha-dr-jeffrey-jones-role-venetoclax-cll/ This time Dr. Jones and Brian discussed the latest data in novel combination therapies in CLL – what combinations result in better outcomes, and which don’t seem to. You can see it here. http://cllsociety.org/2016/08/eha-2016-jeff-jones-novel-combination-therapies-cll/ TRANSLATION AVAILABLE: Just an FYI, in the upper left hand corner of the CLL Society website is a “Translate” button. You can now select your preferred language to learn about CLL. Thanks to everyone who participated in the Reader Poll from the Q2 2016 issue of The CLL Tribune. We will share the results in the next issue of the newsletter.From time to time, we will make you aware of in-person meetings coming up for those of us affected by CLL, specifically:· September 21st at 6 PM at the New York Marriott East Side in New York City: The Lymphoma Research Foundation will be hosting Updates on Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma as part of their Ask the Doctor series. Rick Furman from New York Presbyterian – Weill Cornell Medical (also part of the CLL Society Medical Advisory Board) is the featured speaker. Dinner will be served and there is no charge to attend. You can find out more information and register here. http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=9419387
In the meantime….Stay strong.We are all in this together.
If you want a personal response, or just want to stay in touch, please email me at [email protected]. I have no other way of contacting. Thanks. Stay strong. After all, we are all in this together. And please visit our website: http://cllsociety.org for the latest news and information.
